ONCS Stock Price, News & Analysis
Company Description
ONCS (NASDAQ: ONCS) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $1.7M.
ONCS stock has declined 100.0% over the past year.
This page provides a comprehensive overview of ONCS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ONCS (ONCS) stock. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $1.7M, ONCS is classified as a micro-cap stock.
Latest News
ONCS has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 7 with negative movement. Key topics include offering, fda approval, clinical trial, conferences. View all ONCS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ONCS Company Profile & Sector Positioning
ONCS (ONCS) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.